Literature DB >> 16372263

Effects of oral vitamin C supplementation in hemodialysis patients: a proteomic assessment.

Eva M Weissinger1, Thao Nguyen-Khoa, Christine Fumeron, Claudine Saltiel, Michael Walden, Thorsten Kaiser, Harald Mischak, Tilman B Drüeke, Bernard Lacour, Ziad A Massy.   

Abstract

Evidence indicates that oxidative stress is present in dialysis patients, and is associated with vitamin C deficiency. Limited data are available regarding the effects of vitamin C supplementation on oxidative stress and inflammation markers in these patients. Moreover, there are no data available on plasma polypeptide fingerprints by proteome analysis before and after vitamin C supplementation. Therefore, we analyzed plasma samples from a prospective, randomized, open-labeled trial to assess the effects of oral vitamin C supplementation (250 mg three times per week), to define the plasma polypeptide pattern in hemodialysis patients. Our results reveal that more than 30 polypeptides show significant changes in the dialysis patients in comparison to controls with normal renal function, and that several polypeptides are affected/normalized by oral vitamin C supplementation. These results underline the remarkable potential for proteomics to recognize specific peptide profiles in different pathological situations, which might not be detected by classical methods.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16372263     DOI: 10.1002/pmic.200500210

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  10 in total

Review 1.  Clinical usefulness of novel prognostic biomarkers in patients on hemodialysis.

Authors:  Alberto Ortiz; Ziad A Massy; Danilo Fliser; Bengt Lindholm; Andrzej Wiecek; Alberto Martínez-Castelao; Adrian Covic; David Goldsmith; Gültekin Süleymanlar; Gérard M London; Carmine Zoccali
Journal:  Nat Rev Nephrol       Date:  2011-11-01       Impact factor: 28.314

2.  High-resolution proteome/peptidome analysis of peptides and low-molecular-weight proteins in urine.

Authors:  Harald Mischak; Bruce A Julian; Jan Novak
Journal:  Proteomics Clin Appl       Date:  2007-07-10       Impact factor: 3.494

3.  The use of SDS-PAGE scanning of spent dialysate to assess uraemic toxin removal by dialysis.

Authors:  Alain Ficheux; Nathalie Gayrard; Ilan Szwarc; Daniel Andress; Stéphan Soullier; Yohan Duny; Gilles Goubert; Marie Thomas; Johanna Bismuth-Mondolfo; Jean-Pierre Daurès; Philippe Brunet; Marie-Françoise Servel; Angel Argilés
Journal:  Nephrol Dial Transplant       Date:  2010-12-10       Impact factor: 5.992

4.  Effect of Vitamin C Supplementation on C-reactive Protein Levels in Patients Undergoing Hemodialysis: A Randomized, Double Blind, Placebo-Controlled Study.

Authors:  Vajihe Biniaz; Mehdi Sadeghi Shermeh; Abbas Ebadi; Ali Tayebi; Behzad Einollahi
Journal:  Nephrourol Mon       Date:  2013-11-27

Review 5.  Water-soluble vitamins in people with low glomerular filtration rate or on dialysis: a review.

Authors:  Catherine M Clase; Vincent Ki; Rachel M Holden
Journal:  Semin Dial       Date:  2013-07-17       Impact factor: 3.455

Review 6.  Proteomic Investigations into Hemodialysis Therapy.

Authors:  Mario Bonomini; Vittorio Sirolli; Luisa Pieroni; Paolo Felaco; Luigi Amoroso; Andrea Urbani
Journal:  Int J Mol Sci       Date:  2015-12-10       Impact factor: 5.923

7.  Circulating proteins as predictors of cardiovascular mortality in end-stage renal disease.

Authors:  Tobias Feldreich; Christoph Nowak; Tove Fall; Axel C Carlsson; Juan-Jesus Carrero; Jonas Ripsweden; Abdul Rashid Qureshi; Olof Heimbürger; Peter Barany; Peter Stenvinkel; Nicolas Vuilleumier; Philip A Kalra; Darren Green; Johan Ärnlöv
Journal:  J Nephrol       Date:  2018-11-29       Impact factor: 3.902

8.  Plasma protein characteristics of long-term hemodialysis survivors.

Authors:  Yao-Ping Lin; Chih-Yu Yang; Chen-Chung Liao; Wen-Chung Yu; Chin-Wen Chi; Chao-Hsiung Lin
Journal:  PLoS One       Date:  2012-07-06       Impact factor: 3.240

9.  The effect of vitamin C on parathyroid hormone in patients on hemodialysis with secondary hyperparathyroidism: a double blind, placebo-controlled study.

Authors:  Vajihe Biniaz; Eghlim Nemati; Ali Tayebi; Mehdi Sadeghi Shermeh; Abbas Ebadi
Journal:  Nephrourol Mon       Date:  2013-11-13

Review 10.  From old uraemic toxins to new uraemic toxins: place of 'omics'.

Authors:  Ziad A Massy; Sophie Liabeuf
Journal:  Nephrol Dial Transplant       Date:  2018-10-01       Impact factor: 5.992

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.